1. Mulinde J. The clinical trial enterprise: defining quality. Paper presented at: DIA Quality Risk Management Conference; December 3, 2012; Philadelphia, PA.
2. Meeker-O’Connell. Update on clinical trials transformation initiative (CTTI) quality-by-design project. Paper presented at: DIA Quality Risk Management Conference; December 3, 2012; Philadelphia, PA.
3. Draft guidance on reporting information regarding falsification of data. Fed Regist. 2010;75(33):7412–7426.
4. United Kingdom Medicines and Healthcare Products Regulatory Agency. Guidance for notification of serious breaches of GCP or the trial protocol, Version 5, Final 060114. 2014.
5. Hamrell MR. Raising suspicions with the Food and Drug Administration: detecting misconduct. Sci Eng Ethics. 2010;16(4):697–704.